KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Net Cash Flow: 2017-2025

Historic Net Cash Flow for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$43.9 million.

  • Twist Bioscience's Net Cash Flow fell 43.65% to -$18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.9 million, marking a year-over-year increase of 27.25%. This contributed to the annual value of -$43.9 million for FY2025, which is 27.25% up from last year.
  • As of FY2025, Twist Bioscience's Net Cash Flow stood at -$43.9 million, which was up 27.25% from -$60.3 million recorded in FY2024.
  • Over the past 5 years, Twist Bioscience's Net Cash Flow peaked at $373.1 million during FY2021, and registered a low of -$91.0 million during FY2023.
  • Over the past 3 years, Twist Bioscience's median Net Cash Flow value was -$60.3 million (recorded in 2024), while the average stood at -$65.0 million.
  • In the last 5 years, Twist Bioscience's Net Cash Flow skyrocketed by 696.75% in 2021 and then plummeted by 123.26% in 2022.
  • Yearly analysis of 5 years shows Twist Bioscience's Net Cash Flow stood at $373.1 million in 2021, then tumbled by 123.26% to -$86.8 million in 2022, then dropped by 4.81% to -$91.0 million in 2023, then surged by 33.73% to -$60.3 million in 2024, then climbed by 27.25% to -$43.9 million in 2025.